5 Results for "

PDE10A1

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "PDE10A1" in MCE Product Catalog:

Cat. No.: HY-177295
CAS No.: 2572566-11-9
Synonyms: LY3549492
Naperiglipron (LY3549492) is an orally active Glucagon-like peptide 1 receptor (GLP-1R) agonist with an EC50 of 1.14 nM for hGLP-1R. Naperiglipron significantly decreases the level of blood glucose in GLP-1R knock-in mouse models. Naperiglipron inhibits PDE10A1 enzyme activity (IC50: 7.43 μM) with a weak hERG inhibitory activity. Naperiglipron can be used for type II diabetes mellitus (T2DM) and obesity research .
loading...
    loading...
Cat. No.: HY-A0165
CAS No.: 22345-47-7
Research Areas:  

Neurological Disease

Tofisopam, a 2,3-benzodiazepine compound, is an orally active anxiolytic agent. Tofisopam can inhibit phosphodiesterase PDE isoenzyme activity, withIC50 values of 2.11 μM, 1.98 μM, 0.42 μM, and 0.92 μM for PDE-2A3, PDE-3A, PDE-4A1, and PDE-10A1, respectively. Tofisopam can be used for the study of anxiety .
loading...
    loading...
Cat. No.: HY-12813
CAS No.: 1516896-09-5
Purity:  99.44%
Research Areas:  

Neurological Disease

PDE10-IN-1 is a potent PDE10-IN-1 inhibitor extracted from Patent WO 2013192273 A1, for treating CNS and metabolic disorders.
loading...
    loading...
Cat. No.: HY-A0165R
CAS No.: 22345-47-7
Tofisopam (Standard) is the analytical standard of Tofisopam (HY-A0165). This product is intended for research and analytical applications. Tofisopam, a 2,3-benzodiazepine compound, is an orally active anxiolytic agent. Tofisopam can inhibit phosphodiesterase PDE isoenzyme activity, withIC50 values of 2.11 μM, 1.98 μM, 0.42 μM, and 0.92 μM for PDE-2A3, PDE-3A, PDE-4A1, and PDE-10A1, respectively. Tofisopam can be used for the study of anxiety .
loading...
    loading...
Cat. No.: HY-120945
CAS No.: 1354404-30-0
Research Areas:  

Neurological Disease

PDE10A-IN-1 is a phosphodiesterase 10A (PDE10A) inhibitor with an IC50 of 250 nM and the ability to cross the blood-brain barrier. PDE10A-IN-1 can be used in research on neurological disorders such as schizophrenia .
loading...
    loading...